NCT07743879

Brief Summary

This randomized controlled trial compares the efficacy of therapeutic ultrasound alone, neurodynamic techniques alone, and combined therapeutic ultrasound and neurodynamic techniques in patients with mild to moderate carpal tunnel syndrome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 25, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 26, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 29, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 4, 2026

Completed
Last Updated

August 4, 2026

Status Verified

July 1, 2026

Enrollment Period

8 months

First QC Date

July 29, 2026

Last Update Submit

July 31, 2026

Conditions

Keywords

therapeutic ultrasoundneurodynamic techniquesnerve conduction studyconservative management

Outcome Measures

Primary Outcomes (3)

  • Pain Intensity

    Measure Description: Measured using the unabbreviated Visual Analog Scale (VAS). This scale ranges from 0 to 10 cm, where 0 represents no pain and 10 represents the worst imaginable pain. Higher scores indicate a worse outcome (greater pain intensity).

    Baseline and 6 weeks post-intervention

  • Symptom Severity

    Measure Description: Assessed using the unabbreviated Boston Carpal Tunnel Questionnaire Symptom Severity Scale (BCTQ-SSS). The scale ranges from 1 to 5, with higher scores indicating a worse outcome (more severe symptoms).

    Baseline and 6 weeks post-intervention

  • Functional Status

    Measure Description: Assessed using Boston Carpal Tunnel Questionnaire Functional Status Scale (BCTQ-FSS). The scale ranges from 1 to 5, with higher scores indicating a worse outcome (greater functional disability/impairment).

    Baseline and 6 weeks post-intervention

Study Arms (3)

Therapeutic Ultrasound Group

EXPERIMENTAL

Continuous therapeutic ultrasound applied to the volar wrist at 1.5 W/cm² for 8 to 10 minutes per session, 3 times per week for 6 weeks.

Other: Neurodynamic Techniques

Neurodynamic Techniques Group

EXPERIMENTAL

Median nerve neurodynamic mobilization (progressing from sliders to tensioners), 3 sets of 10 repetitions, 3 times per week for 6 weeks.

Other: Neurodynamic Techniques

Combined Therapy Group

EXPERIMENTAL

Combined application of therapeutic ultrasound followed by neurodynamic techniques in the same session, 3 times per week for 6 weeks.

Other: Neurodynamic Techniques

Interventions

Median nerve neurodynamic mobilization (progressing from sliders to tensioners), 3 sets of 10 repetitions.

Combined Therapy GroupNeurodynamic Techniques GroupTherapeutic Ultrasound Group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of mild to moderate carpal tunnel syndrome confirmed by electrophysiological testing.
  • Age between 18 and 65 years.
  • Presence of symptoms (pain, numbness, tingling) for at least 3 months.

You may not qualify if:

  • History of previous carpal tunnel release surgery or wrist trauma.
  • Corticosteroid injection into the wrist within the past 3 months.
  • Cervical radiculopathy, polyneuropathy, or other upper extremity neurological disorders.
  • Pregnancy or lactation.
  • Contraindications to therapeutic ultrasound (e.g., active infection, metallic implants in the treatment area, malignant tumors).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ibb University

Ibb, nine, Yemen

Location

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor and Head of the Department of Human Medicine

Study Record Dates

First Submitted

July 29, 2026

First Posted

August 4, 2026

Study Start

February 25, 2025

Primary Completion

November 1, 2025

Study Completion

November 26, 2025

Last Updated

August 4, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Not applicable as there is no current plan to share individual participant data publicly.

Locations